NEW YORK (GenomeWeb News) – The US Court of Appeals for the Federal Circuit today upheld an earlier decision denying Myriad Genetics' request for an injunction against Ambry Genetics to prevent it from marketing a BRCA1 and BRCA2 gene test.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.
An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.
The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.
For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.